Spacelabs Healthcare has announced it has received FDA clearance for its Capnography Pod, according to a news release.
The Capnography Pod is described as a compact, sidestream gas analyzer compatible with the company's new qube patient monitor, which received FDA clearance earlier this year. The device provides a non-invasive method of measuring the concentration of carbon dioxide in a gas mixture.
"Capnography is widely recognized as enhancing patient safety particularly with regard to patients who control their pain medication via pump," said Nicholas Ong, president of Spacelabs Healthcare, in the release. "This is a very valuable tool that allows caregivers to be notified, for example, if a patient's breathing is becoming compromised as a result of overmedicating."
Spacelabs Healthcare is headquartered in Issaquah, Wash.
Related Articles on FDA Clearances:
Stryker Receives FDA Approval for Clot Retriever
GeNO Receives FDA Clearance for Inhaled Nitric Oxide Drug Delivery Device
Philips and Celsion Receive FDA Clearance for Phase II Study of Bone Cancer Device